(Q43651420)

English

Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy

scientific article published in July 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy (English)

1 reference

Europe PubMed Central

25 November 2017

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

Burger AJ

1

1 reference

Europe PubMed Central

25 November 2017

Elkayam U

2

1 reference

Europe PubMed Central

25 November 2017

Neibaur MT

3

1 reference

Europe PubMed Central

25 November 2017

Haught H

4

1 reference

Europe PubMed Central

25 November 2017

Ghali J

5

1 reference

Europe PubMed Central

25 November 2017

Horton DP

6

1 reference

Europe PubMed Central

25 November 2017

Aronson D

7

1 reference

Europe PubMed Central

25 November 2017

language of work or name

0 references

publication date

1 July 2001

1 reference

Europe PubMed Central

25 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

25 November 2017

88

1 reference

Europe PubMed Central

25 November 2017

1

1 reference

Europe PubMed Central

25 November 2017

35-39

1 reference

Europe PubMed Central

25 November 2017

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Sympathoinhibitory effects of atrial natriuretic factor in normal humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Effect of atrial natriuretic peptide on muscle sympathetic activity and its reflex control in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Inotropic therapy for heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Parenteral inotropic support for advanced congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Electrophysiologic and proarrhythmic effects of intravenous inotropic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Effect of milrinone on ventricular arrhythmias in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Lack of long-term ventricular arrhythmia reduction by enalapril in heart failure. SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Cardiac sympathetic responses to acute vasodilation. Normal ventricular function versus congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901581-8

7 January 2021

Identifiers

10.1016/S0002-9149(01)01581-8

1 reference

Europe PubMed Central

25 November 2017

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43651420&oldid=2102327150"